Status:
COMPLETED
Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe:
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions:
Pancreas Disease
Eligibility:
All Genders
18+ years
Brief Summary
A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ...
Detailed Description
The European registry for Minimally Invasive Pancreatic Surgery (E-MIPS) is an E-AHPBA endorsed registry with the aim to monitor and safeguard the introduction of MIPD in Europe. International multice...
Eligibility Criteria
Inclusion
- \- Data from all patients who underwent R-MIPD and L-MIPD between January 1st 2019 and December 31st 2021 were included
Exclusion
- Other pancreatic procedures
- Hybrid approaches (reconstruction phase open)
- Procedures with insufficient baseline data / missing primary outcome data.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
1336 Patients enrolled
Trial Details
Trial ID
NCT06135233
Start Date
January 1 2019
End Date
January 1 2022
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC, locatie AMC
Amsterdam, North Holland, Netherlands, 1105 AZ